Suppr超能文献

[过敏性急症]

[Allergic emergencies].

作者信息

Herr A-C, Biedermann T, Brockow K

机构信息

Klinik und Poliklinik für Dermatologie und Allergologie am Biederstein, Technische Universität München, Biedersteiner Str. 29, 80802, München, Deutschland.

出版信息

Hautarzt. 2018 May;69(5):352-363. doi: 10.1007/s00105-018-4163-0.

Abstract

Both anaphylactic reactions and angioedema in the head and neck area can be life-threatening and require emergency treatment. Therapy needed is primarily directed by the patient's symptoms. The first measures taken should consist of immediate disruption of the allergen contact, adequate positioning of the patient, the insertion of an intravenous catheter and an emergency call. In case of cardiovascular or respiratory involvement, intramuscular ± inhalative adrenalin is the treatment of choice. In case of cardiovascular involvement, volume substitution by intravenous catheter and oxygen administration are crucial and in lower airway obstruction, additionally short-acting beta mimetics should be inhaled. Intravenous H1-antihistamines and glucocorticoids are added. Allergic reaction confined to the skin and mucosal surfaces without respiratory involvement or to the gastrointestinal tract should also be treated with intravenous H1-antihistamines and glucocorticoids. Angioedema in the head and neck area can, however, also be associated with a life-threatening upper airway obstruction. Histamine-induced angioedema should be treated as anaphylaxis involving the upper respiratory tract. In hereditary angioedema, or in unclassified angioedema unresponsive to therapy, early airway maintenance and subcutaneous injection of bradykinin-receptor antagonist icatibant, intravenous injection of C1-inhibitor concentrate or fresh frozen plasma is recommended. The same approach should be taken for severe angiotensin converting enzyme inhibitor-induced angioedema with dyspnea. Intubation by skilled personal is indicated in inspiratory stridor and dyspnea at rest. In all cases of anaphylaxis or angioemdema, patients should be surveyed until a safe remission is achieved.

摘要

过敏性反应以及头颈部血管性水肿都可能危及生命,需要紧急治疗。所需治疗主要依据患者症状来指导。首先采取的措施应包括立即中断与过敏原的接触、使患者处于适当体位、插入静脉导管并拨打急救电话。若出现心血管或呼吸系统受累情况,肌肉注射 ± 吸入肾上腺素是首选治疗方法。若出现心血管受累,通过静脉导管进行容量替代和给予氧气至关重要;若出现下气道梗阻,还应吸入短效β受体激动剂。同时添加静脉注射H1抗组胺药和糖皮质激素。局限于皮肤和黏膜表面且无呼吸系统受累或仅累及胃肠道的过敏反应,也应采用静脉注射H1抗组胺药和糖皮质激素进行治疗。然而,头颈部血管性水肿也可能伴有危及生命的上气道梗阻。组胺诱导的血管性水肿应按累及上呼吸道的过敏反应进行治疗。对于遗传性血管性水肿或对治疗无反应的未分类血管性水肿,建议早期维持气道并皮下注射缓激肽受体拮抗剂艾替班特、静脉注射C1抑制剂浓缩物或新鲜冷冻血浆。对于伴有呼吸困难的严重血管紧张素转换酶抑制剂诱导的血管性水肿,也应采取同样的方法。出现吸气性喘鸣和静息时呼吸困难时,应由熟练人员进行插管。在所有过敏反应或血管性水肿病例中,应对患者进行监测,直至实现安全缓解。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验